新华社北京11月3日电 题：惩治"阴阳价"！定点药店岂能"看人下菜碟" 新华社记者彭韵佳 同一家药店同一款感冒药，非医保参保人购买是17元，参保人购买却变成31元，相差近一倍。网友 吐槽"药店先问刷不刷医保，再推荐，满满套路"。药店"看人下菜碟"的"阴阳价"行为，侵蚀医保基金安 全，损害参保人切身利益，削弱公众对医保制度的信任，必须坚决整治。 定点药店敢冒着风险搞"阴阳价"，一方面是部分药店为了缓解经营压力，把成本悄悄转嫁给医保患 者；另一方面，一些药品定价不透明，参保人对药价不敏感，也给了"阴阳价"可乘之机。 医保定点资格不是"免检牌照"，而是诚信经营的"责任状"。坚决惩治"阴阳价"，让购药更公平透 明，让医保基金用在"刀刃"上，才能让百姓更安心、更放心。 医保基金是老百姓的"看病钱""救命钱",一分一厘不容侵占。针对医保定点药店搞"阴阳价"，近日出 台的《关于进一步加强对定点零售药店药品"阴阳价格"监测处置的通知》明确，应予严肃核查处置。 打"痛"，才能让不法药店不敢再犯。惩治"阴阳价"，需要医保、市场监管、药监等部门协同发力、 惩治加力。对执行"阴阳价格"的定点药店，视情节严重程度和整改情况，采取约谈、 ...

一瓶口服溶液挂网价558元，而同通用名普通片剂价格仅约8元，近70倍的价差背后，是亟待厘清的研发 成本，还是隐藏不当营销的灰色空间？ 云南省医疗保障局的一纸问询函，将上市公司百利天恒的全资子公司——四川百利药业推至聚光灯下。 9月24日，云南医保局就百利药业生产的马来酸依那普利口服溶液挂网价格高达558元发出公开问询，要 求其说明价格构成、销售利润、价差合理性及是否存在不当营销等四项问题。 这并不是该产品首次因价格问题引发关注。就在十天前的9月15日，上海阳光医药采购网已发布通知， 暂停包括该口服溶液在内的15个品规药品采购资格。接连被两地监管机构重点关注，折射出当前药品价 格监管的高压态势。 高价的质疑：剂型差异能否支撑70倍价差？ 马来酸依那普利是一种经典的血管紧张素转化酶抑制剂（ACEI），广泛用于治疗原发性高血压、肾性 高血压和充血性心力衰竭。该药的主流剂型为片剂，已多次被纳入国家集采，价格大幅下降。 以扬子江药业生产的马来酸依那普利片为例，经过集采两轮降价，从每盒19.15元降至5.66元，降幅达 70.4%。相比之下，百利药业生产的口服溶液剂型挂网价高达558元，与集采片剂形成近70倍的价差。 结 ...

Core Viewpoint - There is a significant price discrepancy between online and offline pharmacies for the same medications, with some prices being more than three times higher in physical stores compared to online platforms [1][2][5]. Group 1: Price Discrepancy - A survey of ten pharmacies revealed that the same medication can have a price difference of over three times between online and offline sales [1][6]. - For example, the "仁和" artificial cow bile metronidazole capsules cost 8.68 yuan online but 32 yuan offline, resulting in a difference of 23.32 yuan [1][6]. - Other examples include "可益甘" artificial cow bile metronidazole capsules priced at 5.8 yuan online and 15.8 yuan offline, and "百多邦" mupirocin ointment at 19.2 yuan online versus 23.2 yuan offline [5][6]. Group 2: Reasons for Price Differences - Pharmacy staff indicated that online prices are often lower due to platform subsidies, although not all medications follow this trend [2][9]. - Consumers have the option to choose between online and offline purchases based on their preferences, but online shopping may incur additional delivery fees [2][9]. - Legal experts noted that the price difference alone does not constitute price fraud; it must be assessed in the context of whether the pharmacy transparently communicates the reasons for the price difference [11][12]. Group 3: Regulatory Responses - The National Medical Insurance Administration has issued directives to compare offline pharmacy prices with online platforms to address unreasonable pricing [10]. - Local regulations have been established, such as in Shaanxi Province, where offline prices cannot exceed 20% of the online price displayed by the same pharmacy [10]. - Zhejiang Province has mandated that online prices should not exceed 1.3 times the listed price, emphasizing the need for price consistency across different sales channels [10].